Flonseno 25 mikrograma/50 mikrograma po potisku, stlačeni inhalat, suspenzija
| Name | Flonseno 25 mikrograma/50 mikrograma po potisku, stlačeni inhalat, suspenzija |
|---|---|
| Marketing Authorisation Number | HR-H-989832615 |
| Active Substance | salmeterolksinafoat flutikazonpropionat |
| Composition | jedna odmjerna doza sadrži 25 mikrograma salmeterola u obliku salmeterolksinafoata i 50 mikrograma flutikazonpropionata |
| Pharmaceutical Form | Stlačeni inhalat, suspenzija |
| Manufacturer | Alkaloid - INT d.o.o., Ljubljana - Črnuče, Slovenija |
| Marketing Authorisation Holder | Alkaloid - INT d.o.o., Šlandrova ulica 4, Ljubljana - Črnuče, Slovenija |
| Marketing Authorisation Date | 29.06.2023 |
| MA Period of Validity | 29.06.2028 |
| Classification Number | UP/I-530-09/22-01/101 |
| Registration Number | 381-12-01/154-23-08 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | R03AK06 |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
